Cleared Traditional

K101325 - STELLARIS PC VISION ENHANCEMENT SYSTEM

K101325 is the FDA 510(k) clearance for STELLARIS PC VISION ENHANCEMENT SYSTEM by Bausch & Lomb, Inc.. It is a Class 2 Ophthalmic device (product code HQC) cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K101325 · Bausch & Lomb, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2010
Decision
97d
Days
Class 2
Risk

K101325 is an FDA 510(k) clearance for the STELLARIS PC VISION ENHANCEMENT SYSTEM. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Bausch & Lomb, Inc. (Rochester, US). The FDA issued a Cleared decision on August 17, 2010 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Bausch & Lomb, Inc. devices

Submission Details

510(k) Number K101325 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 12, 2010
Decision Date August 17, 2010
Days to Decision 97 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 110d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Consultant

Intertek Testing Services
DANIEL W LEHTONEN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HQC Unit, Phacofragmentation

All 73
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K101325.
EVA, anterior machine, EVA, combined machine, EVA combined machine with laser (DORC connector), EVA combined machine with laser (SMA connector)
K190875 · D.O.R.C. Dutch Ophthalmic Research Center (International) · Sep 2019
COMPACT INTUITIV System, COMPACT INTUITIV Wireless Remote Control, COMPACT INTUITIV Four-Button Foot Pedal, COMPACT INTUITIV Closed-Toe Foot Pedal
K191933 · Johnson & Johnson Surgical Vision, Inc. · Aug 2019
xPORT Lens Fragmentation System
K191024 · Carl Zeiss Meditec Cataract Technology, Inc. · Aug 2019
BAUSCH & LOMB STELLARIS MICROSURGICAL SYSTEM
K082473 · Bausch & Lomb, Inc. · Jan 2009
BAUSCH & LOMB D4600A AIR EXCHANGE LINE PACK
K082132 · Bausch & Lomb, Inc. · Aug 2008
STERILS SINGLE-USE I/A HANDPIECES
K073023 · Bausch & Lomb, Inc. · Mar 2008